The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon Team wins TARDEC Contract

3 Feb 2010 07:00

RNS Number : 5701G
Sopheon PLC
03 February 2010
 



 

 

3 February 2010

 

Sopheon Among Winners of Army Tank Automotive Research Development

and Engineering Center (TARDEC) Contract

 

Sopheon Teams with Concurrent Technologies Corporation and Twenty-Eight Others to Support Military Program for Development of Manned and Unmanned Vehicles

 

MINNEAPOLIS and LONDON-Feb. 3, 2010-Sopheon, the international provider of software and services for product lifecycle management, today announced that it is part of a team of organizations working with Concurrent Technologies Corporation (CTC) on a contract that CTC was awarded under the U.S. Army Tank Automotive Research Development and Engineering Center (TARDEC) Omnibus Program. The Program is intended to provide TARDEC with resources to augment its in-house capabilities in the development of manned and unmanned military ground vehicles.

 

The contract team of which Sopheon is a member under the TARDEC Omnibus Program encompasses 30 supplier and resource organizations led by Concurrent Technologies Corporation (CTC). The consortium includes large and small corporations, small disadvantaged businesses, not-for-profits and universities. The contract provides CTC with the opportunity to propose competitively on Cost Plus Fixed Fee (CPFF) and Firm Fixed Price (FFP) orders relating to TARDEC's overall mission as the U.S. government's primary research and development activity for military vehicle systems. The amount of business coming to Sopheon will depend on which CTC proposals are accepted by TARDEC. The contract is a five-year, multi-award, Indefinite Delivery Indefinite Quantity (IDIQ) agreement with a potential overall value to the consortium of up to $430 million.

TARDEC is part of the U.S. Army Research, Development and Engineering Command (RDECOM). It is the Department of Defense's full lifecycle engineering support provider for all manned and unmanned ground vehicle systems. TARDEC's mission includes working with Life Cycle Management Command (LCMC) and Training and Doctrine Command (TRADOC) stakeholders to maintain a strong, advanced science and technology base in order to address the warfighters' needs with innovative capabilities.

 

The TARDEC contract is the latest development in Sopheon's successful efforts to establish a strong business beachhead in aerospace and defense (A&D) markets. The company launched its strategy for entering the sector less than three years ago. Since that time, its base of A&D customers has grown steadily, including such organizations as BAE Systems, EG&G, Honeywell, Lockheed Martin, Northrop Grumman, QinetiQ, Textron and the U.S. Navy and Air Force. The U.S. Army's Ground Vehicle/Power and Mobility (GVPM) Program Office within TARDEC is also a user of Sopheon's software.

 

"Our strategic focus on A&D markets is still relatively young," said David Vangeison, Sopheon's director for federal, aerospace and defense markets. "But our early experience has validated that this will be an area of great opportunity for us in the years ahead. Sopheon's participation in TARDEC's Omnibus Program underscores our commitment to realizing this potential. Along with our teammates, we look forward to working closely with TARDEC to provide the resources they need to augment their existing capabilities."

 

Enquiries

Barry Mence, Chairman

Sopheon plc

Tel : + 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

Tel : + 44 (0) 1483 685 735

Justine James / Kirsty Corcoran

Hansard Communications

Tel : + 44 (0) 207 245 1100

Floor van Maaren

Citigate First Financial

Tel : + 31 (0) 205 754 010

Sarah Jacobs

Seymour Pierce Corporate Finance

Tel: +44 (0) 20 7107 8000

 

About Concurrent Technologies Corporation

Concurrent Technologies Corporation (CTC) is an independent, nonprofit, applied scientific research and development professional services organization, providing innovative management and technology-based solutions to government and industry. As a nonprofit 501(c)(3) organization, CTC's primary purpose and programs are to undertake applied scientific research and development activities that service the public interest. For more information, please

visit www.ctc.com.

 

 

About Sopheon

Sopheon (LSE:SPE) is an international provider of product lifecycle management software and services that improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenues and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFSRFTIFIII
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.